CRMD - CorMedix Inc.
11.16
2.130 19.086%
Share volume: 4,184,978
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$9.03
2.13
0.24%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-09-2024 | 08-14-2024 | 10-30-2024 | 03-25-2025 | |
| Total revenue | 0.000 | 1.306 M | 11.456 M | 30.710 M | |
| Cost of revenue | 818.539 K | 509.839 K | 686.598 K | 1.176 M | |
| Gross profit | -818.539 K | 296.280 K | 10.770 M | 30.034 M | |
| 136.20% | 3,534.91% | 178.88% | |||
| Operating expenses | 15.886 M | 8.210 M | 7.308 M | 2.498 M | |
| Selling general and admin | 15.048 M | 7.559 M | 6.581 M | 770.787 K | |
| Research and development | 837.445 K | 650.988 K | 727.119 K | 1.727 M | |
| Total expenses | 15.886 M | 15.597 M | 14.057 M | 17.098 M | |
| -1.82% | -9.88% | 21.64% | |||
| Operating income | -16.704 M | -15.301 M | -3.287 M | 12.936 M | |
| Ebit | -16.708 M | -15.302 M | -3.321 M | 13.464 M | |
| Pretax income | -15.861 M | -14.151 M | -2.777 M | 13.464 M | |
| -10.78% | -80.38% | -584.89% | |||
| Income tax | -1.395 M | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -14.466 M | -14.151 M | -2.777 M | 13.464 M | |
| 2.17% | 80.38% | 584.89% |
